900000000000509007: United States of America English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\US English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
US English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
7q partial monosomy (disorder)	Preferred (foundation metadata concept)
7q partial trisomy	Preferred (foundation metadata concept)
7q partial trisomy (disorder)	Preferred (foundation metadata concept)
7q11.23 microduplication syndrome	Preferred (foundation metadata concept)
7q11.23 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
7q11.23 microduplication syndrome is a rare chromosomal anomaly syndrome resulting from the partial duplication of the long arm of chromosome 7 characterized by a highly variable phenotype that typically manifests with mild-moderate intellectual delay (patients could be in the normal range), speech disorders (particularly of expressive language), and distinctive craniofacial features (brachycephaly, broad forehead, straight eyebrows, broad nasal tip, short philtrum, thin upper lip and facial asymmetry). Hypotonia, developmental coordination disorders, behavioral problems (such as anxiety, ADHD and oppositional disorders) and various congenital anomalies, such as heart defects, diaphragmatic hernia, renal malformations and cryptorchidism, are frequently presented. Neurological abnormalities (visible on MRI) have been reported.	Preferred (foundation metadata concept)
7q31 microdeletion syndrome	Preferred (foundation metadata concept)
7q31 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
7q36.3 microduplication syndrome	Acceptable (foundation metadata concept)
7s IgM	Acceptable (foundation metadata concept)
7th floor	Acceptable (foundation metadata concept)
8	Preferred (foundation metadata concept)
8	Preferred (foundation metadata concept)
8 (qualifier value)	Preferred (foundation metadata concept)
8 French gauge	Preferred (foundation metadata concept)
8 French gauge (qualifier value)	Preferred (foundation metadata concept)
8 hour urine specimen	Preferred (foundation metadata concept)
8 hours	Preferred (foundation metadata concept)
8 hours (qualifier value)	Preferred (foundation metadata concept)
8 mm caliber bullet	Preferred (foundation metadata concept)
8 mm caliber bullet, device	Acceptable (foundation metadata concept)
8 mm caliber bullet, device (physical object)	Preferred (foundation metadata concept)
8 month examination abnormal - for observation	Preferred (foundation metadata concept)
8 month examination abnormal - for observation (finding)	Preferred (foundation metadata concept)
8 month examination abnormal - on treatment	Preferred (foundation metadata concept)
8 month examination abnormal - on treatment (finding)	Preferred (foundation metadata concept)
8 month examination abnormal - referred	Preferred (foundation metadata concept)
8 month examination abnormal - referred (finding)	Preferred (foundation metadata concept)
8 o'clock position	Preferred (foundation metadata concept)
8 o'clock position (qualifier value)	Preferred (foundation metadata concept)
8 o'clock position on mammogram	Preferred (foundation metadata concept)
8 o'clock position on mammogram (finding)	Preferred (foundation metadata concept)
8 week examination abnormal - for observation	Preferred (foundation metadata concept)
8 week examination abnormal - for observation	Preferred (foundation metadata concept)
8 week examination abnormal - for observation (finding)	Preferred (foundation metadata concept)
8 week examination abnormal - for observation (finding)	Preferred (foundation metadata concept)
8 week examination abnormal - on treatment	Preferred (foundation metadata concept)
8 week examination abnormal - on treatment	Preferred (foundation metadata concept)
8 week examination abnormal - on treatment (finding)	Preferred (foundation metadata concept)
8 week examination abnormal - on treatment (finding)	Preferred (foundation metadata concept)
8 week examination abnormal - referred	Preferred (foundation metadata concept)
8 week examination abnormal - referred	Preferred (foundation metadata concept)
8 week examination abnormal - referred (finding)	Preferred (foundation metadata concept)
8 week examination abnormal - referred (finding)	Preferred (foundation metadata concept)
8,11,14-eicosatrienoic acid	Preferred (foundation metadata concept)
8,11,14-eicosatrienoic acid (substance)	Preferred (foundation metadata concept)
8-9 month exam normal	Preferred (foundation metadata concept)
8-9 month exam normal	Preferred (foundation metadata concept)
8-9 month exam normal (finding)	Preferred (foundation metadata concept)
8-9 month exam normal (finding)	Preferred (foundation metadata concept)
8-9 month exam not attended	Preferred (foundation metadata concept)
8-9 month exam not attended	Preferred (foundation metadata concept)
8-9 month exam not attended (situation)	Preferred (foundation metadata concept)
8-9 month exam not attended (situation)	Preferred (foundation metadata concept)
8-9 month exam not offered	Preferred (foundation metadata concept)
8-9 month exam not offered	Preferred (foundation metadata concept)
8-9 month exam not offered (situation)	Preferred (foundation metadata concept)
8-9 month exam not offered (situation)	Preferred (foundation metadata concept)
8-9 month exam not wanted	Preferred (foundation metadata concept)
8-9 month exam not wanted	Preferred (foundation metadata concept)
8-9 month exam not wanted (situation)	Preferred (foundation metadata concept)
8-9 month exam not wanted (situation)	Preferred (foundation metadata concept)
8-9 month examination abnormal - for observation	Preferred (foundation metadata concept)
8-9 month examination abnormal - for observation (finding)	Preferred (foundation metadata concept)
8-9 month examination abnormal - on treatment	Preferred (foundation metadata concept)
8-9 month examination abnormal - on treatment (finding)	Preferred (foundation metadata concept)
8-9 month examination abnormal - referred	Preferred (foundation metadata concept)
8-9 month examination abnormal - referred (finding)	Preferred (foundation metadata concept)
8-9 month examination abnormal: for observation	Preferred (foundation metadata concept)
8-9 month examination abnormal: for observation (procedure)	Preferred (foundation metadata concept)
8-9 month examination abnormal: on treatment	Preferred (foundation metadata concept)
8-9 month examination abnormal: on treatment (situation)	Preferred (foundation metadata concept)
8-9 month examination abnormal: referred	Preferred (foundation metadata concept)
8-9 month examination abnormal: referred (situation)	Preferred (foundation metadata concept)
8-He	Acceptable (foundation metadata concept)
8-Hydroxyloxapine measurement	Preferred (foundation metadata concept)
8-Hydroxyloxapine measurement (procedure)	Preferred (foundation metadata concept)
8-L-lysine-vasopressin preparation	Acceptable (foundation metadata concept)
8-Lathosterol	Preferred (foundation metadata concept)
8-Lathosterol (substance)	Preferred (foundation metadata concept)
8-MOP	Acceptable (foundation metadata concept)
8-amino-7-oxononanoate synthase	Preferred (foundation metadata concept)
8-amino-7-oxononanoate synthase (substance)	Preferred (foundation metadata concept)
8-aminoquinoline	Preferred (foundation metadata concept)
8-aminoquinoline (substance)	Preferred (foundation metadata concept)
8-dehydrocholesterol	Preferred (foundation metadata concept)
8-dehydrocholesterol (substance)	Preferred (foundation metadata concept)
8-hydroxy amoxapine	Acceptable (foundation metadata concept)
8-hydroxy-5-deazaflavin-reducing hydrogenase	Acceptable (foundation metadata concept)
8-hydroxy-deoxyguanosine	Preferred (foundation metadata concept)
8-hydroxy-deoxyguanosine (substance)	Preferred (foundation metadata concept)
8-hydroxyamoxapine	Preferred (foundation metadata concept)
8-hydroxyamoxapine (substance)	Preferred (foundation metadata concept)
8-hydroxyamoxapine measurement	Preferred (foundation metadata concept)
8-hydroxyamoxapine measurement (procedure)	Preferred (foundation metadata concept)
8-hydroxydeoxyguanosine	Acceptable (foundation metadata concept)
8-hydroxyfuranocoumarin O^8^-methyltransferase	Preferred (foundation metadata concept)
8-hydroxyfuranocoumarin O^8^-methyltransferase (substance)	Preferred (foundation metadata concept)
8-hydroxyloxapine	Preferred (foundation metadata concept)
8-hydroxyloxapine (substance)	Preferred (foundation metadata concept)
8-hydroxyquercetin 8-O-methyltransferase	Preferred (foundation metadata concept)

Start Previous Page 133 of 13176 Next End

Reference Sets

Reference set descriptor

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001115012	United States of America English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001116013	US English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001117016	United States of America English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)